future view

How can we make the process of developing medications faster, safer, and less costly?

19 October 2020 • 1 min reading time

An ever-greater understanding of disease processes has made it possible to develop medications that are customised for specific patients or groups of patients. However, the process is expensive, time-consuming, and risky. TNO is working on innovations to make it easier to develop medications more quickly, more safely, and cost effectively.

Care to learn more?

Download the position paper

Download

Our starting point is that the innovations should be designed to accelerate the process. After all, a shorter and more efficient development process would reduce costs and result in medications being available more quickly. One such cost-saving innovation is the Accelerator Mass Spectrometry (AMS). This is a unique technology that could prevent delays in the development of new medications. Other examples are a 3D printer for printing ‘custom-made’ medications, an organ-on-a-chip, and models of organs for reducing the likelihood of new medications failing during the clinical trial phase.

But the fact is that the only way of making substantial improvements to the process by which medications are developed is to do so in a coordinated and concerted manner. We should then be in a position to develop ever-more complex and personalised medications for patients, using less animal testing and at an acceptable level of cost.

Six important aspects

Below are the most important recommendations for the pharmaceutical industry and government for successfully accelerating the process:

  • Identify the bottlenecks that lead to higher costs and greater risks, as well as the opportunities for accelerating that process.
  • A coordinated approach, involving government, industry, and TNO (as an independent knowledge partner) could make possible the development of more complex medications at an acceptable cost.
  • With a coordinated approach, government and industry could make more targeted investments in relevant process innovations.
  • By being directly involved, the government could introduce and implement the necessary regulations more quickly.
  • More carefully targeted innovation would reduce the risks, while an integrated approach for speeding up the process could save billions of euros.
  • In a dialogue between the pharmaceutical industry and government, these savings should feed through to lower prices for medications.

Want to join us in improving drug development of the future?

Get in touch with Ivana Bobeldijk

Contact

Inventors' Day

9 Nov '21 - 5 min
At TNO, our inventors have been working on the inventions and innovations of tomorrow since 1932. In the context of Inventor's Day, we reflect on some of TNO's inventors... Read more
innovation

TNO staff get to grips with the nitrogen crisis with the Brains4nitrogen programme

15 Oct '21 - 4 min
Following the success of the Brains4corona programme, in which TNO focused on tackling the coronavirus in 2020, the organisation is now planning to launch more of... Read more
innovation

TNO's Brains4x accelerates innovation on societal challenges in the Netherlands

15 Oct '21 - 2 min
From the corona pandemic to the nitrogen crisis: the Netherlands is facing major challenges. After the success of Brains4corona and Brains4nitrogen, TNO will organize... Read more
future view

Smart sensors for a healthy and safe working environment

14 Jan '21 - 4 min
The effects of occupational illnesses are far-reaching. Every year, thousands of people die as a result of long-term exposure to hazardous substances. That has to... Read more
future view

Biomarkers personalise medical treatment

13 Nov '20 - 4 min
Until the start of the millennium, every metastatic lung cancer patient received more or less the same treatment. We now know that there are different types of lung... Read more